Hypoxia induces CXCR4 expression and biological activity in gastric cancer cells through activation of hypoxia-inducible factor-1α

Oncology Reports

Volumn 28, Issue 6, 2012, Pages 2239-2246

  Oh, Yoon Suk ^a   Kim, Ha Yon ^a   Song, Ik Chan ^a   Yun, Hwan Jung ^a   Jo, Deog Yeon ^a   Kim, Samyong ^a   Lee, Hyo Jin ^a  

^a Chungnam National University   (South Korea)

Author keywords

CXCR4; Gastric cancer; Hypoxia; Hypoxia inducible factor 1

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SHORT HAIRPIN RNA; STROMAL CELL DERIVED FACTOR 1;

BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CANCER INVASION; CELL HYPOXIA; CELL MIGRATION; CELL MOTILITY; CONFERENCE PAPER; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; STOMACH CANCER; TRANSCRIPTION INITIATION; UPREGULATION; WESTERN BLOTTING; WOUND HEALING;

CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CXCL12; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RECEPTORS, CXCR4; RNA INTERFERENCE; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION; WOUND HEALING;

EID: 84868121439     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2063     Document Type: Conference Paper

References (49)

1. Kamangar F, Dores GM and Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137-2150, 2006. (Pubitemid 46655601)
2. Lee HJ, Cho Do Y, Park JC, et al: Phase II trial of biweekly paclitaxel plus infusional 5-fuorouracil and leucovorin in patients with advanced or recurrent inoperable gastric cancer. Cancer Chemother Pharmacol 63:427-432, 2009.
3. Cheng WL, Wang CS, Huang YH, Tsai MM, Liang Y and Lin KH: Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer. Ann Oncol 22:2267-2276, 2011.
4. Lee HJ, Huang SM, Kim HY, et al: Evaluation of the combined expression of chemokine SDF-1 alpha and its receptor CXCR4 as a prognostic marker for gastric cancer. Exp Ther Med 2:499-504, 2011.
5. Shen Z, Seppanen H, Vainionpaa S, et al: IL10, IL11, IL18 are differently expressed in CD14 (+) TAMs and play different role in regulating the invasion of gastric cancer cells under hypoxia. Cytokine 59:352-357, 2012.
6. Song IC, Liang ZL, Lee JC, et al: Expression of stromal cellderived factor-1α is an independent risk factor for lymph node metastasis in early gastric cancer. Oncol Lett 2:1197-1202, 2011.
7. Fiegl M, Samudio I, Clise-Dwyer K, Burks JK, Mnjoyan Z and Andreeff M: CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure. Blood 113:1504-1512, 2009.
8. Muller A, Homey B, Soto H, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50-56, 2001. (Pubitemid 32225831)
9. Richard CL, Tan EY and Blay J: Adenosine upregulates CXCR4 and enhances the proliferative and migratory responses of human carcinoma cells to CXCL12/SDF-1alpha. Int J Cancer 119:2044-2053, 2006. (Pubitemid 44423660)
10. Sun X, Cheng G, Hao M, et al: CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev 29:709-722, 2010.
11. Wang Y, Li Z, Zhang H, et al: HIF-1alpha and HIF-2alpha correlate with migration and invasion in gastric cancer. Cancer Biol Ther 10:376-382, 2010.
12. Wang X, Li C, Chen Y, et al: Hypoxia enhances CXCR4 expression favoring microglia migration via HIF-1alpha activation. Biochem Biophys Res Commun 371:283-288, 2008.
13. Schioppa T, Uranchimeg B, Saccani A, et al: Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med 198:1391-1402, 2003. (Pubitemid 37392484)
14. Krishnamachary B, Berg-Dixon S, Kelly B, et al: Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 63:1138-1143, 2003. (Pubitemid 36278449)
15. Ishikawa T, Nakashiro K, Klosek SK, et al: Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma. Oncol Rep 21:707-712, 2009.
16. Cronin PA, Wang JH and Redmond HP: Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4. BMC Cancer 10:225, 2010.
17. Schutyser E, Su Y, Yu Y, et al: Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells. Eur Cytokine Netw 18:59-70, 2007. (Pubitemid 47262360)
18. Lee HJ, Lee K, Lee DG, et al: Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor. Clin Cancer Res 18:3270-3280, 2012.
19. Kwak MK, Hur K, Park DJ, et al: Expression of chemokine receptors in human gastric cancer. Tumour Biol 26:65-70, 2005. (Pubitemid 40827606)
20. Yasumoto K, Koizumi K, Kawashima A, et al: Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res 66:2181-2187, 2006.
21. Lee HJ, Kim SW, Kim HY, et al: Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer. Int J Oncol 34:473-480, 2009.
22. Pituch-Noworolska A, Drabik G, Szatanek R, et al: Immunophenotype of isolated tumour cells in the blood, bone marrow and lymph nodes of patients with gastric cancer. Pol J Pathol 58:93-97, 2007. (Pubitemid 47121541)
23. Sun XJ, Sun KL, Zheng ZH, et al: Gene expression patterns in gastric cancer. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23:142-146, 2006.
24. Hashimoto I, Koizumi K, Tatematsu M, et al: Blocking on the CXCR4/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells. Eur J Cancer 44:1022-1029, 2008.
25. Tsuboi K, Kodera Y, Nakanishi H, et al: Expression of CXCL12 and CXCR4 in pT3-stage gastric cancer does not correlate with peritoneal metastasis. Oncol Rep 20:1117-1123, 2008.
26. Iwasa S, Yanagawa T, Fan J and Katoh R: Expression of CXCR4 and its ligand SDF-1 in intestinal-type gastric cancer is associated with lymph node and liver metastasis. Anticancer Res 29:4751-4758, 2009.
27. Arigami T, Natsugoe S, Uenosono Y, et al: CCR7 and CXCR4 expression predicts lymph node status including micrometastasis in gastric cancer. Int J Oncol 35:19-24, 2009.
28. Zhao BC, Wang ZJ, Mao WZ, et al: CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma. World J Gastroenterol 17:2389-2396, 2011.
29. Ding YL, Zhang JL, Tang SF, Fu QY and Li ZT: Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer. Zhonghua Yi Xue Za Zhi 88:202-205, 2008 (In Chinese).
30. Koizumi K, Kato S, Sakurai H, Hashimoto I, Yasumoto K and Saiki I: Therapeutics target of CXCR4 and its downstream in peritoneal carcinomatosis of gastric cancer. Front Biosci (Schol Ed) 4:269-276, 2012.
31. Noda S, Yashiro M, Nshii T and Hirakawa K: Hypoxia upregulates adhesion ability to peritoneum through a transforming growth factor-beta-dependent mechanism in diffuse-type gastric cancer cells. Eur J Cancer 46:995-1005, 2010.
32. Hockel M, Schlenger K, Hockel S and Vaupel P: Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res 59:4525-4528, 1999. (Pubitemid 29428951)
33. Zhong H, De Marzo AM, Laughner E, et al: Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59:5830-5835, 1999.
34. Hynes RO: Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants-or both? Cell 113:821-823, 2003. (Pubitemid 36792026)
35. Griffiths EA, Pritchard SA, Welch IM, Price PM and West CM: Is the hypoxia-inducible factor pathway important in gastric cancer? Eur J Cancer 41:2792-2805, 2005. (Pubitemid 41713116)
36. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U and Vaupel P: Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56:4509-4515, 1996. (Pubitemid 26330463)
37. Generali D, Berruti A, Brizzi M P, et al: Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer. Clin Cancer Res 12:4562-4568, 2006. (Pubitemid 44297805)
38. Bachtiary B, Schindl M, Potter R, et al: Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer. Clin Cancer Res 9:2234-2240, 2003. (Pubitemid 36687648)
39. Schindl M, Schoppmann SF, Samonigg H, et al: Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res 8:1831-1837, 2002. (Pubitemid 34633742)
40. Pan J, Mestas J, Burdick MD, et al: Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis. Mol Cancer 5:56, 2006.
41. Phillips RJ, Mestas J, Gharaee-Kermani M, et al: Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/ mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha. J Biol Chem 280:22473-22481, 2005. (Pubitemid 40827903)
42. Shim H, Lau SK, Devi S, Yoon Y, Cho HT and Liang Z: Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha. Biochem Biophys Res Commun 346:252-258, 2006. (Pubitemid 43865990)
43. Kim SW, Kim HY, Lee HJ, Yun HJ, Kim S and Jo DY: Dexamethasone and hypoxia upregulate CXCR4 expression in myeloma cells. Leuk Lymphoma 50:1163-1173, 2009.
44. Sun X, Wei L, Chen Q and Terek RM: CXCR4/SDF1 mediate hypoxia induced chondrosarcoma cell invasion through ERK signaling and increased MMP1 expression. Mol Cancer 9:17, 2010.
45. Dunn LK, Mohammad KS, Fournier PG, et al: Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment. PloS One 4:e6896, 2009.
46. Zagzag D, Lukyanov Y, Lan L, et al: Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab Invest 86:1221-1232, 2006. (Pubitemid 44789912)
47. Mahaseth H and Kaufman J: Optimizing stem cell collection through CXCR4 antagonists. Front Biosci (Schol Ed) 4:611-619, 2012.
48. Gangadhar T, Nandi S and Salgia R: The role of chemokine receptor CXCR4 in lung cancer. Cancer Biol Ther 9:409-416, 2010.
49. Iwanaga T, Iwasaki Y, Ohashi M, Nunobe S and Iwagami S: Establishment of a CXCR4-expressing gastric cancer cell line in nude mice and the effect of AMD 3100 on tumor regression. Gan To Sagaku Ryoho 34:1917-1919, 2007 (In Japanese).